The clinic in Paris has more than 25 years’ experience of lung transplantation and is one of the leading lung transplant clinics in France, with a well-reputed Ex Vivo Lung Perfusion (EVLP) program.
Under the leadership of Professor Alain Chapelier, the clinic in Paris has carried out EVLP using the so-called manual STEEN Solution™ method. “We will now be able to continue to explore EVLP using XPS™ and STEEN Solution™,” says Dr Edouard Sage, who is in charge of the clinical EVLP program.
XPS™ is the only CE-marked and FDA approved integrated system on the market today which gives the user the flexibility to perform evaluation of lungs before transplantation through a standardized and simplified procedure. Use of XPS™ has shown good clinical results at 18 clinics in the US, many of which are national leaders in their field. Six XPS™ contracts have now been signed by European clinics, giving them access to the XPS™ system for lung transplantation, and the company notes continuing high interest for the XPS™ in Europe.
“We are delighted that the FOCH clinic in Paris, which has great experience of transplanting lungs after performing EVLP with STEEN Solution™ with good clinical results, is now moving on to a more standardized and simplified EVLP using the XPS™ system,” says Magnus Nilsson, CEO of XVIVO Perfusion.
February 24, 2016
Gothenburg
XVIVO Perfusion AB (publ)